<?xml version='1.0' encoding='utf-8'?>
<document id="20812772"><sentence text="Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US." /><sentence text="Mortality and morbidity are increased in patients experiencing drug-drug interactions" /><sentence text=" Unfortunately, there is a paucity of literature describing clinically significant drug-drug interactions occurring in the intensive care unit (ICU)" /><sentence text=" Knowing the clinically significant drug-drug interactions allows the opportunity for prevention through knowledge and computer-assisted programmes" /><sentence text="" /><sentence text="To identify significant potential drug-drug interactions occurring in the cardiovascular ICU (CCU) and the cardiothoracic ICU (CTICU)" /><sentence text="" /><sentence text="Prospective, observational study conducted over a total of 8 weeks in February and March 2009" /><sentence text="" /><sentence text="CCU and CTICU in a major academic medical centre (Presbyterian Hospital, University of Pittsburgh Medical Centre)" /><sentence text="" /><sentence text="All adult patients (&gt;or=18 years of age) admitted during 1 month in each ICU" /><sentence text="" /><sentence text="Micromedex and Lexi-Interact interaction databases were used to screen each patient's medication profile daily for the presence of potentially interacting drug pairs that would be considered a potential drug-drug interaction" /><sentence text=" A severity assessment using these databases was completed after a potential drug-drug interaction was identified" /><sentence text="" /><sentence text="The frequency of significant drug-drug interactions, including those that were considered major or contraindicated, according to two commercially available interaction databases" /><sentence text="" /><sentence text="Evaluations of 400 patient medication profiles were conducted, resulting in 225 profiles possessing one or more potential drug-drug interactions" /><sentence text=" A total of 1150 potential interactions were identified, resulting in 287" /><sentence text="5 potential interactions per 100 patient-days" /><sentence text=" Of the 1150 potential drug-drug interactions, 458 were unique interacting drug pairs; 5-9% of the potential interactions were considered major or contraindicated" /><sentence text=" Many of the significant and frequent potential interactions involved blood coagulation modifiers, potential interactions that could result in QTc prolongation, and cytochrome P450 inhibition" /><sentence text=" Micromedex and Lexi-Interact agreed on the severity ratings in 20" /><sentence text="5% of the potential interactions" /><sentence text="" /><sentence text="Significant potential drug-drug interactions occur in the CCU and CTICU, highlighting the need for active surveillance to potentially prevent patient harm" /><sentence text=" Clinicians should also consider using two references for identifying interactions, due to the lack of congruence between sources" /><sentence text="" /></document>